Types of ligands

From Proteopedia
Revision as of 17:03, 13 September 2021 by Alexander Berchansky (talk | contribs)
Jump to navigation Jump to search

Under construction!

In biochemistry and pharmacology, a ligand is a substance that forms a complex with a biomolecule to serve a biological purpose.

Ligands include:

Substrates

Inhibitors

Activators

Signaling lipids

Neurotransmitters

A ligand that can bind to and alter the function of the receptor that triggers a physiological response is called a receptor agonist.

Endogenous agonists:

Examples of agonists:

  • acts as a 1alpha,25(OH)(2)D(3) superagonist of Vitamin D on Vitamin D receptor and exhibits both antiproliferative and prodifferentiating properties in vitro.
  • in Transport inhibitor response 1 (3c6o). Water molecules are shown as red spheres.
  • of human Bile acid receptor ligand-binding domain (deeppink) complex with non-steroidal agonist, nuclear receptor coactivator 1 peptide (cyan) and sulfate ions (PDB entry 3ruu). [1]

Ligands that bind to a receptor but fail to activate the physiological response are receptor antagonists.

  • participates directly in agonist/competitive antagonist binding, affects activation gating, and is the portion that forms the 'middle' layer.
in the structure of Glutamate receptor (GluA2).
The small molecule [2], was studied as a treatment for stroke because it had demonstrated neuroprotective efficacy in experimental models of stroke and tolerability in healthy volunteers; however, in a multicenter, double-blind, randomized, placebo-controlled phase II trial, it was found to have significant sedative effects in patients with acute stroke which precludes its further development as a neuroprotective agent[3].

Human CXCR4 receptor with cyclic peptide ligand (antagonist) CVX15 (PDB code 3oe0)

Drag the structure with the mouse to rotate

ReferencesReferences

  1. Akwabi-Ameyaw A, Caravella JA, Chen L, Creech KL, Deaton DN, Madauss KP, Marr HB, Miller AB, Navas F 3rd, Parks DJ, Spearing PK, Todd D, Williams SP, Wisely GB. Conformationally constrained farnesoid X receptor (FXR) agonists: Alternative replacements of the stilbene. Bioorg Med Chem Lett. 2011 Aug 11. PMID:21890356 doi:10.1016/j.bmcl.2011.08.034
  2. Turski L, Huth A, Sheardown M, McDonald F, Neuhaus R, Schneider HH, Dirnagl U, Wiegand F, Jacobsen P, Ottow E. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10960-5. PMID:9724812
  3. Walters MR, Kaste M, Lees KR, Diener HC, Hommel M, De Keyser J, Steiner H, Versavel M. The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovasc Dis. 2005;20(5):304-9. Epub 2005 Aug 30. PMID:16131799 doi:10.1159/000087929

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky